duced hepatitis is often diagnosed by exclusion, so that the To evaluate the incidence, severity, and course of ketopossibility of hepatitis C virus (HCV) infection has not been conazole-associated hepatic injury, 211 patients with excluded in most reports, because serological markers for onychomycosis were randomized by a ratio of 2:1 to re-HCV were not available before 1989. 27 Therefore, we have ceive either ketoconazole (137 patients) or griseofulvin conducted this controlled, cohort study to examine the inci-(74 patients). All of them were seronegative for hepatitis dence, severity, and clinical course of ketoconazole-induced B surface antigen (HBsAg) and anti-hepatitis C virus hepatic injury.
believed and that transient subclinical injury is muchFollow-up. After the start of ketoconazole or griseofulvin therapy, more common than overt hepatitis. Therapy with ketotests for serum AST and ALT were scheduled in all patients once conazole may be continued with caution in the absence every 2 weeks for the first 3 months, and at monthly intervals thereof symptoms and/or hyperbilirubinemia, but should be after during the course of therapy. After a serum AST or ALT elevadiscontinued if overt hepatitis occurs. (HEPATOLOGY tion was detected, patients were monitored closely with clinical 1997;25:103-107.) evaluation and weekly serum AST, ALT, alkaline phosphatase, gglutamyl transpeptidase, and bilirubin measurements until normalization. It was determined before the study that ketoconazole or Ketoconazole, an imidazole derivative, has been used griseofulvin was to be discontinued promptly if clinical symptoms of widely in the treatment of systemic fungal infections.1 Sevhepatitis or hyperbilirubinemia develeped. Complete blood cell leveral case reports of mild to severe hepatic injury, including els, its differential counts, and serological markers of hepatitis A icteric and fatal cases, have been published 2-26 with an esti-virus, B virus, delta virus, and HCV, as well as anti-nuclear antibody mated incidence of symptomatic hepatic injury of 1:15,000 to and anti-smooth muscle antibody titers, were also studied when ap-1:2,000. 15,16,18 In addition, the transient asymptomatic in-propriate. Liver biopsy was routinely advised when abnormal AST crease of serum transaminase has also been reported in some or ALT levels were detected, but was performed in only one patient patients 2,3,14,[20][21][22] HDV (anti-HD) were assayed using commercial radioimmunoassays North Chicago, IL). Anti-HCV was assayed using a second-genera- Received February 5, 1996; accepted August 16, 1996. tion enzyme immunoassay